2,6-Lutidine → N-(5-tert-butyl-3-methanesulfonylamino-2-methoxy-phenyl)-4-methyl-3-(4-pyridin-3-yl-[1,2,3]triazol-1-yl)-benzamide

HRID 2109174ノート

反応式

HRID 2109174 の反応式
[CH3:1][C:2]1[CH:10]=[CH:9][C:5]([C:6]([OH:8])=O)=[CH:4][C:3]=1[N:11]1[CH:15]=[C:14]([C:16]2[CH:17]=[N:18][CH:19]=[CH:20][CH:21]=2)[N:13]=[N:12]1.C(Cl)(=O)C(Cl)=O.[NH2:28][C:29]1[C:30]([O:44][CH3:45])=[C:31]([NH:39][S:40]([CH3:43])(=[O:42])=[O:41])[CH:32]=[C:33]([C:35]([CH3:38])([CH3:37])[CH3:36])[CH:34]=1.N1C(C)=CC=CC=1C>C(Cl)Cl.CN(C=O)C.C1COCC1>[C:35]([C:33]1[CH:32]=[C:31]([NH:39][S:40]([CH3:43])(=[O:42])=[O:41])[C:30]([O:44][CH3:45])=[C:29]([NH:28][C:6](=[O:8])[C:5]2[CH:9]=[CH:10][C:2]([CH3:1])=[C:3]([N:11]3[CH:15]=[C:14]([C:16]4[CH:17]=[N:18][CH:19]=[CH:20][CH:21]=4)[N:13]=[N:12]3)[CH:4]=2)[CH:34]=1)([CH3:38])([CH3:36])[CH3:37]

参加物

8

反応物 4

HCID 79372,6-LutidineHCID 65578Oxalyl chlorideHCID 10214710N-(3-amino-5-tert-butyl-2-methoxy-phenyl)-methanesulfonamideHCID 210973314-Methyl-3-(4-pyridin-3-yl-1,2,3-triazol-1-yl)-benzoic acid

生成物 1

HCID 21097217N-(5-tert-butyl-3-methanesulfonylamino-2-methoxy-phenyl)-4-methyl-3-(4-pyridin-3-yl-[1,2,3]triazol-1-yl)-benzamide

試薬・触媒・溶媒 3

HCID 6228Dimethylformamide触媒HCID 6344Dichloromethane溶媒HCID 8028Tetrahydrofuran溶媒

実験手順

4-Methyl-3-(4-pyridin-3-yl-1,2,3-triazol-1-yl)-benzoic acid (76.3 mg; 0.272 mmol) was suspended in 5 mL of CH2Cl2, and 1 mL of THF, and 0.04 mL (0.4 mmol) of oxalyl chloride was added. One drop of DMF was then added to the stirring suspension, and the mixture was stirred for 2 h. The resulting cloudy solution was concentrated to dryness and suspended in CH2Cl2. N-(3-Amino-5-tert-butyl-2-methoxy-phenyl)-methane-sulfonamide (81 mg; 0.30 mmol) was added, then 0.06 mL (0.5 mmol) of 2,6-lutidine, and the resulting solution was stirred overnight. The mixture was then washed with 1M NaHSO4, saturated NaHCO3, and brine. The organic portion was dried with Na2SO4, filtered, and concentrated. Chromatography (0-6.5% MeOH in CH2Cl2), with careful selection of only the pure fractions, provided 80 mg (0.15 mmol; 55%) of Example 14. ESI MS m/z 535 [C27H30N6O4S+H]+.

後処理

  1. concentrationThe resulting cloudy solution was concentrated to dryness
  2. washThe mixture was then washed with 1M NaHSO4, saturated NaHCO3, and brine
  3. dry with materialThe organic portion was dried with Na2SO4
  4. filtrationfiltered
  5. concentrationconcentrated
  6. customChromatography (0-6.5% MeOH in CH2Cl2), with careful selection of only the pure fractions, provided 80 mg (0.15 mmol; 55%) of Example 14

出典と根拠

ORDレコード
ord-fd0af20833874a808635d89f9ff130f5
出典データセット
uspto-grants-2009_04
特許番号
US07514458B2

反応ノート

読み込み中…